Key result
PCI plus OMT cuts MACE ~24% compared to medical therapy alone.
Why the study?
Studies comparing PCI plus optimal medical therapy versus optimal medical therapy alone in chronic total occlusion are limited by observational design, variable follow-up, diverse outcomes, and high drop-out and cross-over rates.
Does percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) reduce major adverse cardiovascular events (MACE) in patients with chronic total occlusion (CTO)?
Meta-Analysis
Does percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) reduce major adverse cardiovascular events (MACE) in patients with chronic total occlusion (CTO)?
Relative Risk: 0.76 (95% CI 0.61–0.95)
p-value: p=<0.00001
PCI combined with optimal medical therapy significantly reduces long-term MACE, all-cause mortality, and cardiac death compared to medical therapy alone in patients with chronic total occlusion.
PCI+OMT may improve CTO outcomes in selected patients; leaves open definitive practice change pending larger RCTs.
Studies comparing the outcome of percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) versus OMT alone in treatment of chronic total occlusion (CTO) are limited by observational design, variable follow-up period, diverse clinical outcomes, high drop-out and cross-over rates. This study aims to conduct a meta-analysis of published data of observational as well as randomized studies comparing long term outcomes of PCI+OMT versus OMT alone. PubMed, Embase and Cochrane databases were systematically reviewed. 15 studies meeting criteria were included in the meta-analysis. The New-castle Ottawa scale was used to appraise the overall quality of the studies. Random-effects model with inverse variance method was undertaken. Major adverse cardiovascular events (MACE) which comprises of cardiac death, myocardial infarction, stroke, and un-planned revascularization were significantly lower in the PCI+OMT group (RR:0.76; 95% CI:0.61 to 0.95; P=<0.00001; I2 = 85%). All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P=<0.00001 in both). Myocardial infarction and stroke rates were lower in the PCI+OMT group, however they did not reach statistical significance (P = 0.24, P = 0.15 respectively). Unplanned revascularizations (of any vessel) were also similar in both the groups (P = 0.78, I2 = 88%). PCI of CTO is rewarded with better long term outcome, in terms of MACE, all-cause mortality and cardiac death with similar rates of un-planned revascularization.
No takes yet. Share an insight, caveat, or question.
Khanra et al. (2020) conducted a meta-analysis in Chronic total occlusion (CTO). Percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) vs. Optimal medical therapy (OMT) alone was evaluated on Major adverse cardiovascular events (MACE) comprising cardiac death, myocardial infarction, stroke, and un-planned revascularization (RR 0.76, 95% CI 0.61 to 0.95, p=<0.00001). Percutaneous coronary intervention plus optimal medical therapy significantly reduced major adverse cardiovascular events compared to medical therapy alone (RR 0.76; 95% CI 0.61-0.95; P<0.00001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: